文献速递其他结缔组织病

新冠疫苗接种与美国退伍军人特发性炎性肌病发病无关

COVID-19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-03-13

该病例对照研究在美国退伍军人中比较了新发特发性炎性肌病(IIM)患者与无IIM对照的既往新冠疫苗接种情况。89例新发IIM患者与445例对照匹配后,未发现疫苗接种与IIM发病存在统计学显著关联。

要点

  • 新冠疫苗接种后30天或90天内,IIM发病风险与对照无显著差异。
  • 多项其他比较亦未发现疫苗接种与IIM发病存在显著关联。
  • 这是首个将接种疫苗后肌炎风险与对照人群比较的研究。

核心结论

  • 本研究未发现新冠疫苗接种后发生特发性炎性肌病(IIM)的风险增加。

研究设计与样本

  • 病例对照研究,纳入美国退伍军人健康管理局(VHA)中经病历复核确认的新发IIM病例,按1:5匹配无IIM对照。

主要发现

  • 89例新发IIM患者与445例对照匹配,7例(7.9%)病例和29例(6.5%)对照在索引日期前30天内接种首剂新冠疫苗(OR 1.22,P=0.643;调整OR 1.12,P=0.657)。
  • 11例(12.4%)病例和68例(15.3%)对照在索引日期前90天内接种首剂疫苗(OR 0.78,P=0.479;调整OR 0.74,P=0.402)。
  • 其他多项比较均未发现新冠疫苗接种与IIM之间存在统计学显著关联。

临床怎么用

  • 临床中不应因担心诱发IIM而推迟或避免新冠疫苗接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Several case reports have proposed a potential association between COVID-19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID-19 vaccination in US veterans who developed new-onset IIM compared to those without new-onset IIM. METHODS: For this case-control study, new-onset incident cases of IIM were veterans enrolled in the Veterans Health Administration (VHA) with at least two IIM International Classification of Diseases (ICD) codes, at least one year of VHA enrollment before the first IIM ICD code, and chart review confirming incident IIM. Each IIM incident case was matched 1:5 to control patients without IIM who had similar age, sex, race, specialty clinic visits for the first IIM diagnostic code, and year of specialty clinic visit. RESULTS: The 89 patients with new-onset incident IIM identified were matched to 445 controls without IIM. Seven (7.9%) case patients and 29 (6.5%) control patients received their first COVID-19 vaccination within 30 days before the index date (odds ratio [OR] 1.22, P = 0.643; adjusted OR 1.12, P = 0.657), and 11 (12.4%) case patients and 68 (15.3%) control patients received their first vaccination within 90 days of the index date (OR 0.78, P = 0.479; adjusted OR 0.74, P = 0.402). Multiple other comparisons also failed to identify a statistically significant association between COVID-19 vaccination and IIM. CONCLUSION: This study is the first to compare the risk of developing myositis after receiving COVID-19 vaccination to that of a control population. This comparison did not identify a risk for developing IIM after COVID-19 vaccination.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Hernández C, Schlesinger N, Rojas J, et al. COVID-19 Vaccination Is Not Associated With the Development of Idiopathic Inflammatory Myositis in US Veterans. Arthritis Care Res (Hoboken). 2026. PMID: 41449568. doi:10.1002/acr.70023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。